ALT · Altimmune, Inc.
$2.81
-0.06 (-2.09%)
At close · Jul 20
Market Cap
$546.47M
Shares
194.47M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-16 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-13 | — | |
| 8-K | 2026-04-24 | 2026-04-22 | |
| 8-K | 2026-04-16 | — | |
| DEF 14A | 2026-03-17 | 2026-04-16 | |
| 10-K | 2026-03-06 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2026-02-03 | 2026-02-02 | |
| 8-K | 2026-01-28 | 2026-01-27 | |
| 8-K | 2025-12-19 | — | |
| 8-K | 2025-12-01 | 2025-11-30 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-03 | 2025-10-01 | |
| 8-K | 2025-09-25 | — | |
| DEF 14A | 2025-08-15 | 2025-09-25 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-26 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-03-13 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | 2025-02-24 | |
| 8-K | 2025-02-25 | 2025-02-24 | |
| 8-K | 2024-12-11 | 2024-11-15 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 8-K | 2024-09-26 | — | |
| 8-K | 2024-08-15 | 2024-08-13 | |
| DEF 14A | 2024-08-15 | 2024-09-26 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-26 | 2024-06-25 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-03-27 | — | |
| 10-K | 2024-03-27 | 2023-12-31 | |
| 8-K | 2023-11-30 | — | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-09-28 | — | |
| DEF 14A | 2023-08-16 | 2023-09-28 | |
| 8-K | 2023-08-10 | — | |
| 10-Q | 2023-08-10 | 2023-06-30 |
Showing 1–50 of 104 filings
Key facts
CIK
1326190
CUSIP
02155H200
13F (30d)
15 filings
15 filers
Visit website
Investor relations